FOXD1 and head and neck squamous cell carcinoma: Another study by us showed that the expression of FOXD1 could serve as an independent prognosticator for head and neck squamous cell carcinoma, which indicated that adding the expression of FOXD1 into the prognostic assessment tool, such as TNM system, could improve the prognostic prediction [31].